Vineet Laboratories — 360° view

Vineet Laboratories, a company in the Pharmaceuticals industry, reported revenue of ₹14 crore and net profit of ₹0.12 crore for the September 2026 quarter.

Vineet Laboratories (NSE: VINEETLAB) closed at ₹40.06 on 20 Nov 2026. Its market capitalisation is ₹77 crore and it trades at 24.0 times earnings.

Share price
₹40.06 (20 Nov 2026)
Market cap
₹77 Cr (20 Nov 2026)
P/E
23.96 (20 Nov 2026)
Revenue
₹14 Cr (September 2026 quarter)
Net profit
₹0 Cr (September 2026 quarter)
ROCE
8.49% (FY26)
ROE
3.68% (FY26)
Book value
₹24.6 (FY26)
Dividend yield
0.00% (last 12 months to 20 Nov 2026)
52-week high / low
₹41.30 / ₹34.10 (20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: VINEETLAB

Incorporated in 2003, Vineet Laboratories Ltd is in designing, developing, manufacturing of API Intermediates and Bulk Drugs

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.